
In this session, Dr. Seang Lin Tan, MBBS, FRCOG, FRCSC, FACOG, MMed(O&G), MBA, Professor in Obstetrics and Gynaecology, Medical Director, OriginElle Fertility Clinic and Women’s Health Centre; Founding Director, McGill Reproductive Centre has been talking about IVM as an option for poor responders and how can it improve their chances to achieve pregnancy.
Dr. Seang Lin Tan started by defining “In vitro” which means in the laboratory. Thus, In vitro fertilization means fertilization of the eggs outside the body, whereas In vitro maturation means maturing the eggs outside the body.
Typically, in the treatment of IVF, the patients do not necessarily need medication depending on the case. Then, the biggest follicles in the ovary containing the eggs are awaited until they reach a stage when the maturation of eggs is obtained, typically when follicles are up to 20 millimetres in diameter. By that time, if no drugs are prescribed, there is usually only one follicle in the ovary.
On the other hand, if eggs were to be collected with follicles up to 14 millimetres in diameter, most of the eggs would not be mature regardless of some exceptions. Thus, IVM refers to the maturing of these immature eggs in the laboratory.
It is known that a proportion of women undergoing IVF treatment do not respond appropriately to medication. Although it is expected that women over 40 years are not expected to respond to medication, some young women who are in their early 30s with a normal ovarian reserve might also not respond well despite a high or low dose.
Every country has different practices. For instance, in Europe, most doctors stop at 300 or 459 international medications per day while the dose of medication can be as high as 600 units in North America. However, regardless of the dosage and stimulation treatment, if few follicles are developing, patients are called poor responders. Depending on age, the percentage of poor responders can vary significantly.
It is stated that poor responders represent high proportions of women undergoing fertility treatment, as well as patients of advanced maternal age and low ovarian reserve. Some younger patients also unexpectedly demonstrate poor-quality embryos in repeated IVF treatment cycles despite a variety of ovarian stimulation regimes. In such cases, modified natural cycle IVF/IVM can be successfully used.
In Vitro, Maturation of Eggs (IVM) is the maturing of immature eggs in culture after their recovery from small antral follicles. The reasons why IVM is used are the following:
As shown in the chart in conventional IVF, patients are given stimulation protocols, either conventional FSH/hMG dose using antagonist protocols.
While in classical natural cycle IVF, no medications are given yet the patient is monitored until the biggest follicles reach 18 millimetres in diameter, and injection of hCG is given to collect 1 egg.
In Mild IVF, low doses of FSH/hMG along with antagonist or oral compounds are given with the aim of 2- 7 eggs.
The most common way is early stimulation, early trigger modified natural cycle IVF/ IVM. In this method, no drugs are given until the biggest follicles are 14 millimetres in diameter. FHS is given every day until the follicle is 17 or 18 millimetres in diameter.
Early trigger natural cycle IVF IVM without any drugs at all runs a 30% chance of premature ovulation/LH surgery and a 10% pregnancy rate. If the patient has an irregular period, we induce withdrawal bleeding by giving them medication until the follicle is 14 mm. Thanks to this method there was no case of OHSS in over 10 years (>1000 cycles).
It is a simpler treatment and reduces cost because the price of medication in some countries is high. It avoids potential side effects – weight gain, bloating, breast tenderness, nausea, mood swings and OHSS
Case 1 – A 25-year-old lady is reported to have previous severe OHSS.
A tiny dose of Puregon was provided when the 2 biggest follicles were 12 millimetres in diameter. Injection of Dalarelin (which is a GnRHa antagonist) was given afterward. It was possible to collect from her 10 mature eggs and 17 immature eggs. Only 13 of them matured after one day. In a total of 23 matured eggs, only 20 were fertilized by the sperm. Only a grade 2 single embryo was transferred, and she got pregnant and delivered a baby boy. Four good-quality embryos at the blastocyst stage were vitrified.
According to the paper presented in the slide, when comparing IVM to IVF, the results are about the same. In addition, the length of time to perform the egg collection is similar as well as the degree of discomfort, infection, and so forth.
Another paper from Dr Dahan showed a world record of collecting 125 eggs in early stimulation early trigger modified natural cycle IVF and IVM.
Immature eggs are collected for later maturation process in the laboratory. As soon as those eggs are matured, they are fertilized. Otherwise, those eggs will become overmatured.
Unlike IVF where estrogen levels are high due to medication, in IVM medication is not highly requested besides estrogen entrance, which is a preparation of estrogen for oral consumption one tablet three times a day starting on the day of egg collection. The dose or medication depends on the lining of the womb.
As shown in a landmark paper from 1999:
Dr Chen published this paper and presented that the live birth rate was at 40% in those 25 women who went through this IVM protocol.
After ten years the success rate increased from 40% to 56% in the cycle of egg collection while the implantation rate was 20- 23% for each embryo.
In the group where women had previous poor response of IVF, patients were given big doses of medication while in the IVM group, no medication was given. Despite this, both groups produced the same number of eggs at the end, and an average of the same number of embryos transferred. As a result, a pregnancy was achieved in the IVM. Therefore, egg donation is supposedly a viable option for women in this condition.
In conclusion, the injection of hCG increases the number of mature (MII) eggs and the rate of maturation. IVM is useful in unexplained, repeated poor embryo quality or poor responders. IVM in these cases can produce a 35 to 50% pregnancy rate per cycle in young women. Also, obstetric and live birth outcomes of these babies born after IVM/IVF are similar. IVM fresh embryo transfer may not be as good as IVF, but if you freeze the embryos and then transfer them, the pregnancy rate is the same. Early stimulation IVF IVM method may be a first-line approach in the number of patients and can have good results in new centres as well.
I don’t think this is something you should be very worried about. This can happen to some patients, we are talking here about preparing the surrogate for embryo transfer. Sometimes, some women especially, if they’re young do produce functional cysts, and this functional cyst may stay there for a month or two months or three months, but they invariably go with themselves. I think here is where patience is of the virtue because the surrogate is obviously young, I would just wait for the surrogate to have the cyst disappear before starting the cycle. In the meantime, freeze the embryos for the transfer in preparation for the surrogate, that’s all.
We’re talking here about a potential poor responder with a low AMH level. I would say that in most cases, we would try IVF in the first instance. Here, in Montreal and Ottawa, we have had healthy babies born with IVF even if the AMH level is lower than that level. Having said that, if we get a poor response to IVF, then in the case we would use IVM, and we’ve had healthy babies born with IVM. These patients are the ones who are likely to b poor responders.
I would need to know a bit more details about that previous cycle. In principle, as I said, an FSH of 32 and an AMH at 0.2 obviously says that there is an ovarian failure. The irregular periods are probably because of ovarian failure. Now, if the doctor wishes to do IVF, you can try IVF first. However, if you try IVF and you’ll find that there are virtually no eggs, you are the type of patient that is the topic of today’s lecture, we could try IVM. If you live in North America, we would have you come to Montreal for about two weeks and do everything here. If you live in Europe, we could work together with the center in Europe, do a telephone consultation, you would give them our protocol, they could do all the blood work and the essential, tests in Europe, have the first one or two ultrasound scans are done there, and we might give them a small dose of Puregon or Gonal-F f on day-4, day-6, then day-8, as I showed you on the slide. After that, as soon as the biggest follicle is 8-10 millimeters, you would need to come to Montreal or Ottawa, and then after that, as soon as the biggest follicle is 12 to 14 mm, we trigger and collect the eggs. The length of time you’ll need to spend in Canada will be about a week to 10 days if you’re doing a fresh transfer. We can also freeze the embryo, you fly back to Europe, and then you come back as a subsequent time to do the transfer. Nowadays, flying from Europe to Canada is pretty easy except for the pandemic obviously, which changed our lives but normally there are daily flights from London, Paris, Rome, Spain, all the major capitals in Europe, so coming to Montreal or Toronto is very easy. From Montreal, for example, it’s a 1.5 hour or 2-hour drive to Ottawa. We can fly directly to Ottawa as well, then have a stopover in Montreal.
If you exclude the cost of drugs an IVM cycle, we’re talking about 4 to 5 thousand dollars. The cost of drugs depends on where you buy them, you need a bit of a drug. I would suggest buying drugs in Europe because the cost of drugs, in Europe, is a fraction of the cost of drugs in North America. Drugs in North America for IVM might add an extra 1 or 2 thousand dollars, but in Europe, it might cost a couple of hundred dollars.
IVM would be an option. Whether it would be the best option for the next cycle, I can’t really know. In these cases, I would say it’s probably best if you contact us directly. You can send us a copy of your medical file, we could examine it in detail first before giving some advice. The information you’ve provided is just too general. Obviously, 11 fertilized eggs and then to get poor quality embryos in one cycle itself is not an absolute indication for IVM, but it would be an option. It will depend on your age, other factors, the partner’s DNA fragmentation, whether any other factors are important to consider first, whether PGT-A is considered or can be done in your country, and so on.
There are many different ancillary treatments, which can so-called improve egg quality. DHEA, CoQ10 is widely known, there’s Myo-inositol that you can try, there’s MACA from South America that you can try, some people have taken baby aspirin, and so on, but none of these methods are guaranteed to work. We ourselves do give, in some cases, growth hormone to improve egg quality as well. Regarding this method, you should probably discuss it with your own doctor because I would never like to give patients advice that is overruling the patient’s own doctor.
The age limit for IVM is the same as it is for IVF. Some doctors will stop doing IVF for women who are 41-43. They will not do IVM as well in such a case. The law here in Quebec says that it’s not possible to treat a woman with her own eggs if she’s more than 46 years old. Obviously, for IVM, it’s the same, we have to stop it if a woman is 46, but in Ontario, there’s no age limit, so long as the patient has a chance and she understands the chances are small, the treatment can be done.
It’s not the same. Duo-stim is a method of stimulation for IVF. In Duo-stim, what they do is that they will stimulate ovaries by the antagonist protocol, collect all the eggs above about 10 or 12 diameters, and about two days later, after the egg collection, start stimulation again and then do a second egg collection. In our center, we even did the triple stim, and you do get some successes. However, medication cost is expensive because we’re talking about 2 or 3 rounds of egg collections in one cycle. The cost of distribution methods is quite different from IVM, where we are trying to give little medications and collecting eggs when they are immature to be collected. So, no, Duo-Stimulations is not similar to IVM.
+ 2 more answers
+ 3 more answers
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
| Cookie | Duration | Description |
|---|---|---|
| _ga | 2 years | This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors. |
| _gat_UA-38575237-21 | 1 minute | No description |
| _gid | 1 day | This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form. |
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
| Cookie | Duration | Description |
|---|---|---|
| _gat_FSQM52 | 1 minute | No description |
| cf_ob_info | No description | |
| cf_use_ob | No description |